Works matching DE "TYPE 2 diabetes"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Análise do Perfil Clínico de Pessoas com Diabetes Tipo 2: Estudo Transversal.

    Published in:
    Saúde Coletiva, 2025, v. 15, n. 95, p. 15626, doi. 10.36489/saudecoletiva.2025v15i95p15626-15641
    By:
    • Santos da Cruz, João Matheus;
    • de Oliveira, Geovana Borges;
    • de Lima Alves, Gabriel;
    • Sene Pacheco, Edildete;
    • Corrêa da Penha, Jardeliny;
    • Oliveira Almeida, Vinicius;
    • Moura De Araújo, Márcio Flávio;
    • Garcia Lira Neto, José Cláudio
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Reply to Vella and Pai.

    Published in:
    2025
    By:
    • Visioli, Francesco;
    • Del Rio, Daniele;
    • Fogliano, Vincenzo;
    • Marangoni, Franca;
    • Ricci, Cristian;
    • Poli, Andrea
    Publication type:
    Letter
    40

    Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, p. 3, doi. 10.1111/dom.16496
    By:
    • Zargar, Abdul Hamid;
    • Bhansali, Anil;
    • Majumdar, Anirban;
    • Maheshwari, Anuj;
    • Bhattacharyya, Arpandev;
    • Dasgupta, Arundhati;
    • Saboo, Banshi Damodarlal;
    • Sethi, Bipin Kumar;
    • Sanyal, Debmalya;
    • Seshadri, Krishna G.;
    • Deshpande, Neeta Rohit;
    • Kapoor, Nitin;
    • Lakhani, Om Jitendra;
    • Talwalkar, Pradeep Gopal;
    • Kalra, Pramila;
    • Mehrotra, Rabindera Nath;
    • Sahay, Rakesh Kumar;
    • Shukla, Rishi;
    • Kant, Saket;
    • Das, Sambit
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3943, doi. 10.1111/dom.16431
    By:
    • van Baar, Michaël J. B.;
    • Muskiet, Marcel H. A.;
    • Scholtes, Rosalie A.;
    • Touw, Daan J.;
    • Nieuwdorp, Max;
    • Kramer, Mark H. H.;
    • Joles, Jaap A.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • Krebber, Merle M.;
    • van Raalte, Daniël H.
    Publication type:
    Article
    50